The Asthma and Allergy Foundation of America (AAFA) addresses concerns regarding the Final Evidence Report assessing the clinical effectiveness and value of treatments for peanut allergy released by the Institute for Clinical and Economic Review (ICER) on July 10, 2019. ICER’s report may cause concern for the allergy community that the findings will restrict access to new treatments for peanut allergy.
We urge Congress to support the School-Based Allergies and Asthma Management Program Act (H.R. 2468) to put important protections in place for children with asthma and allergies.
In this essay, you’ll hear from Peter DeMarco of Boston, Massachusetts, who lost his wife, Laura Levis, to asthma. Boston ranks #8 on our 2019 Asthma Capitals report. It has such a high ranking because of a high number of people with asthma and asthma-related deaths.
On May 7, 2019, World Asthma Day, the Asthma and Allergy Foundation of America (AAFA) released its 2019 Asthma Capitals Report™. This report ranks the top 100 most challenging places in America to live with asthma.
Show us how you are #morethanasthma for National Asthma and Allergy Awareness Month. Take a picture showing how you overcome asthma barriers and live life fully. Upload it to our online community to enter. Three winners will be selected during May from all eligible photo entries.
Each May since 1984, the Asthma and Allergy Foundation of America (AAFA) has declared May to be National Asthma and Allergy Awareness Month. This month is dedicated to teaching others about asthma and allergies to create more awareness and understanding. We also want to help people see beyond asthma and allergies. This year, we aim to do just that through our themes, “More Than Asthma” and “More Than Food Allergies.”
The Asthma and Allergy Foundation of America (AAFA) has released the 2019 Spring Allergy Capitals™ report to look at why some locations are more affected than others. Our report ranks the top 100 cities in the nation for spring allergies.
Asthma is a chronic lung disease where the airways are inflamed. For many people, asthma can be controlled with medicines and avoiding triggers. But severe asthma is not that simple. How do you know if you have severe asthma?
Dry and/or cold air is a trigger for airway narrowing (bronchoconstriction) and can be a weather-related asthma trigger. When you breathe in cold, dry air through your mouth, the air doesn't get warmed by your nose first. The cold air goes to your lungs and airways. This can trigger an asthma attack. Try these tips to avoid having cold air trigger your asthma.
Asthma is a complex condition. People can have different levels of asthma, triggers and treatments. Whether you’ve just been diagnosed or have had asthma for some time, you may need help making sense of it all. The Asthma and Allergy Foundation of America (AAFA) has created the ASTHMA Care for Adults program. This program covers a full range of topics someone with asthma needs to know.
FDA is alerting patients, caregivers and health care professionals that the labels attached to some EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and the authorized generic versions, may block access to the auto-injector and prevent the ability to easily access the product.
Health care reform has been a big topic in the news for a while now. With so much news on the topic, it can get confusing, especially during the federal Health Insurance Marketplace’s (Healthcare.gov) open enrollment. Here are some things to know about health care for 2019.
If you have asthma or allergies, it is important to have health insurance. Medicine, lab tests, lung function tests and visits to see a specialist all add up. What do you need to know about your insurance options during open enrollment this year?
The Asthma and Allergy Foundation of America (AAFA), the premiere nonprofit representing patients with asthma and allergies, applauds the recent request for information and statement from the Food and Drug Administration (FDA) demonstrating its commitment to explore the classification of sesame as a major allergen.
The Asthma and Allergy Foundation of America (AAFA) led a research study called Atopic Dermatitis in America . The purpose of this study is to shed light on the number of adults who deal with this frustrating skin condition. This week, AAFA has released early findings from the report. One surprising find from the study was the number of adults with AD who say it is moderate to severe. As many as 40% of the people surveyed said they had moderate-to-severe AD. Through this study, we hope to...